Piloting the Affordable Medicines Facility-malaria: What will success look like?;Pilotage du fonds pour des médicaments antipaludéens à des prix abordables: Quel type de succès?

Bulletin of the World Health Organization

Volumn 90, Issue 6, 2012, Pages 452-460

  Yamey, Gavin ^a   Schäferhoff, Marco ^b   Montagu, Dominic ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SEEK Development   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN;

ACCESSIBILITY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMMODITY; DEVELOPING WORLD; DISEASE TREATMENT; DRUG PRESCRIBING; HEALTH GEOGRAPHY; HEALTH SERVICES; MALARIA; PUBLIC HEALTH; SENSITIVITY ANALYSIS; TUBERCULOSIS;

ARTICLE; COST CONTROL; DEVELOPING COUNTRY; DRUG COST; HEALTH CARE AVAILABILITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; MALARIA; PUBLIC HEALTH; SENSITIVITY ANALYSIS; SOCIAL MARKETING;

ANTIMALARIALS; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALARIA; PILOT PROJECTS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PUBLIC HEALTH; SOCIAL MARKETING; WORLD HEALTH;

EID: 84863639355     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.11.091199     Document Type: Article

References (28)

1. World malaria report. Geneva: World Health Organization;2008. Available from: http://www.who.int/malaria/wmr2008 [accessed 19 January 2012]
2. Moon S, Pérez Casas C, Kindermans J-M, de Smet M, von Schoen-Angerer T. Focusing on quality patient care in the new global subsidy for malaria medicines. PLoS Med 2009;6:e1000106. doi:10.1371/journal.pmed.1000106 PMID:19621068
3. First-line buyers of ACT: eligibility criteria. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2012. Available from: http://www.theglobalfund.org/en/amfm/firstlinebuyers/eligibility/ [accessed 27 January 2012].
4. Affordable Medicines Facility - malaria: technical design. Geneva: Roll Back Malaria Partnership; 2007. Available from: http://www.rbm.who.int/partnership/tf/globalsubsidy/AMFmTechProposal.pdf [accessed 19 January 2012].
5. Understanding the antimalarial market: Uganda 2007. Geneva: Medicines for Malaria Venture; 2007.
6. Independent evaluation of the Affordable Medicines Facility - malaria (Phase 1): inception report. Fairfax, VA: ICF Macro; 2010.
7. Report of Affordable Medicines Facility - malaria, Ad Hoc Commitee. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2009. Available from: http://www.theglobalfund.org/documents/board/19/BM19_07AMFmCommittee_Report_en/ [accessed 27 January 2012].
8. Schäferhoff M, Yamey G. Estimating benchmarks of success in the Affordable Medicines Facility - malaria Phase 1. San Francisco: Evidence-to-Policy Initiative; 2011. Available from: http://www.theglobalfund.org/documents/amfm/E2PI_EstimatingBenchmarksInAMFm_Report_en/ [accessed 19 January 2012].
9. Kangwana B, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, Pandit J, et al. The impact of retail sector delivery of artemether-lumefantrine on effective malaria treatment of children under five in Kenya. Nairobi: Kenya Medical Research Institute; 2009. Available from: http://www.tropika.net/specials/mim2009/session-reports/scientific-session-9-docs/76-Beth-Kangwana-1535-1550hrs.pdf [accessed 19 January 2012].
10. Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D et al. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS ONE 2009;4:e6857. doi:10.1371/journal.pone.0006857 PMID:19724644
11. The impact of subsidized ACTs in Uganda's private sector. Geneva: Medicines for Malaria Venture;2010.
12. Pilot study: private sector distribution of artemisinin-based combination therapy (ACT) in Angola. Preliminary 3rd quarter report, April 2010 to June 2010. Crawley: MENTOR Initiative;2010.
13. Cohen JM, Sabot O, Sabot K, Gordon M, Gross I, Bishop D et al. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Serv Res 2010;10(Suppl 1):S6. doi:10.1186/1472-6963-10-S1-S6 PMID:20594372
14. Kone KG, Ndonky A, Lalou R, Le Hesran J-Y. Subsidized ACTs available for sale in private drugstores: experience in Senegal. Paris: Institute de Recherche pour le Developpement; 2007.
15. Rwanda application form - Affordable Medicines Facility - malaria. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2010. Available from: www.theglobalfund.org/grantdocuments/RWN-R05-ML_AMFmApplication_0_en [accessed 31 January 2012].
16. Sabot OJ, Yeung S, Pagnoni F, Gordon M, Petty N, Schmits K, et al. Distribution of artemisinin-based combination therapies through private sector channels: lessons from four country case studies. Washington: Resources for the Future; 2009. Available from: http://www.rff.org/RFF/Documents/RFF-DP-08-43_FINAL.pdf [accessed 19 January 2012].
17. Childinfo malaria treatment. New York: United Nations Children's Fund; 2012. Available from: http://www.childinfo.org/malaria_tables1.php [accessed 19 January 2012].
18. ACTwatch [internet site]. Available from: http://www.actwatch.info/home/home.asp [accessed 19 January 2012].
19. Five-year evaluation. Study area 3: Impact on HIV, TB, and malaria. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2010. Available from: http://www.theglobalfund.org/en/terg/evaluations/5year/ [accessed 19 January 2012].
20. Purdy CH. Fruity, fun and safe: creating a youth condom brand in Indonesia. Reprod Health Matters 2006;14:127-134. doi:10.1016/S0968-8080(06)28256-9 PMID:17101431
21. Janowitz B, Suazo M, Fried DB, Bratt JH, Bailey PE. Impact of social marketing on contraceptive prevalence and cost in Honduras. Stud Fam Plann 1992;23:110-117. doi:10.2307/1966540 PMID:1604457
22. Tanzania (2006): MAP study evaluating coverage and quality of coverage of Salam, Ngao and WaterGuard. Washington: Population Services International; 2006. Available from: http://www.psi.org/sites/default/files/publication_files/672-tanzania_map_h2o_smrs.pdf [accessed 19 January 2012].
23. ® dans les départements du Bénin. Washington: Population Services International; 2010. Available from: http://www.psi.org/sites/default/files/publication_files/2009-benin_map_h20_ors_msr.pdf [accessed 19 January 2012].
24. Agha S, Do M, Armand F. When donor support ends: the fate of social marketing products and the markets they help create. Bethesda MD: Abt Associates; 2005. Available from: http://pdf.usaid.gov/pdf_docs/PNADF982.pdf [accessed 19 January 2012].
25. Forsberg BC, Petzold MG, Tomson G, Allebeck P. Diarrhoea case management in low- and middle-income countries-an unfinished agenda. Bull World Health Organ 2007;85:42-48. doi:10.2471/BLT.06.030866 PMID:17242757
26. Larson CP, Saha UR, Nazrul H. Impact monitoring of the national scale up of zinc treatment for childhood diarrhea in Bangladesh: repeat ecologic surveys. PLoS Med 2009;6:e1000175. doi:10.1371/journal.pmed.1000175 PMID:19888335
27. Rutherford GW, McFarland W, Spindler H, White K, Patel SV, Aberle-Grasse J et al. Public health triangulation: approach and application to synthesizing data to understand national and local HIV epidemics. BMC Public Health 2010;10:447. doi:10.1186/1471-2458-10-447 PMID:20670448
28. Sabot O, Gordon M, Moonen B, Talisuna A, Amofah G. A path to the optimal future for the Affordable Medicines facility-malaria. Health Policy Plan 2011;26:441-444. doi:10.1093/heapol/czr067